GE Healthcare Technologies Inc (0ADL) Ratios
GE Healthcare Technologies Inc Ratios
GB:0ADL's free cash flow for Q3 2026 was $793.00M. For the 2026 fiscal year, GB:0ADL's free cash flow was decreased by $-114.00M and operating cash flow was $907.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.18 | 1.00 | 1.00 | 1.09 | 0.97 |
| Quick Ratio | 0.93 | 0.79 | 0.78 | 0.79 | 0.68 |
| Cash Ratio | 0.50 | 0.30 | 0.28 | 0.20 | 0.08 |
| Solvency Ratio | 0.10 | 0.11 | 0.09 | 0.14 | 0.31 |
| Operating Cash Flow Ratio | 0.22 | 0.20 | 0.23 | 0.29 | 0.24 |
| Short-Term Operating Cash Flow Coverage | 3.91 | 1.30 | 1.88 | 17.76 | 14.61 |
| Net Current Asset Value | $ -15.61B | $ -14.92B | $ -16.13B | $ -10.13B | $ -2.87B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.28 | 0.30 | 0.31 | 0.02 |
| Debt-to-Equity Ratio | 0.96 | 1.11 | 1.38 | 0.92 | 0.03 |
| Debt-to-Capital Ratio | 0.49 | 0.53 | 0.58 | 0.48 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.48 | 0.47 | 0.54 | 0.47 | 0.00 |
| Financial Leverage Ratio | 3.56 | 3.92 | 4.55 | 2.94 | 1.58 |
| Debt Service Coverage Ratio | 3.31 | 1.56 | 1.67 | 12.69 | 19.60 |
| Interest Coverage Ratio | 6.14 | 5.20 | 4.49 | 29.33 | 69.88 |
| Debt to Market Cap | 0.27 | 0.25 | 0.27 | 0.32 | 0.01 |
| Interest Debt Per Share | 22.90 | 21.67 | 22.87 | 19.21 | 1.05 |
| Net Debt to EBITDA | 1.45 | 1.77 | 2.09 | 2.27 | -0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.99% | 41.71% | 40.52% | 39.14% | 40.80% |
| EBIT Margin | 15.55% | 15.69% | 14.85% | 13.81% | 16.58% |
| EBITDA Margin | 18.35% | 18.64% | 17.97% | 17.26% | 20.13% |
| Operating Profit Margin | 13.39% | 13.34% | 12.45% | 13.75% | 15.89% |
| Pretax Profit Margin | 13.42% | 13.12% | 12.08% | 13.70% | 16.35% |
| Net Profit Margin | 10.10% | 10.13% | 8.02% | 10.45% | 12.78% |
| Continuous Operations Profit Margin | 10.44% | 10.42% | 8.28% | 10.63% | 12.94% |
| Net Income Per EBT | 75.29% | 77.22% | 66.41% | 76.27% | 78.16% |
| EBT Per EBIT | 100.22% | 98.32% | 96.96% | 99.60% | 102.86% |
| Return on Assets (ROA) | 5.65% | 6.02% | 4.83% | 6.96% | 8.54% |
| Return on Equity (ROE) | 20.08% | 23.59% | 21.98% | 20.48% | 13.49% |
| Return on Capital Employed (ROCE) | 9.93% | 11.15% | 10.37% | 12.39% | 14.30% |
| Return on Invested Capital (ROIC) | 8.84% | 8.29% | 6.79% | 9.56% | 11.25% |
| Return on Tangible Assets | 9.35% | 10.56% | 8.58% | 14.51% | 19.42% |
| Earnings Yield | 5.57% | 5.59% | 4.46% | 7.23% | 8.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.21 | 4.50 | 4.53 | 4.59 | 4.64 |
| Payables Turnover | 3.81 | 3.79 | 3.95 | 3.61 | 3.81 |
| Inventory Turnover | 5.54 | 5.91 | 5.93 | 5.18 | 5.35 |
| Fixed Asset Turnover | 6.67 | 7.71 | 7.82 | 7.93 | 7.87 |
| Asset Turnover | 0.56 | 0.59 | 0.60 | 0.67 | 0.67 |
| Working Capital Turnover Ratio | 26.46 | -4918.00 | 59.52 | 89.47 | -27.18 |
| Cash Conversion Cycle | 40.03 | 46.72 | 49.58 | 48.89 | 51.24 |
| Days of Sales Outstanding | 69.99 | 81.19 | 80.55 | 79.46 | 78.69 |
| Days of Inventory Outstanding | 65.88 | 61.72 | 61.51 | 70.47 | 68.22 |
| Days of Payables Outstanding | 95.84 | 96.19 | 92.49 | 101.04 | 95.68 |
| Operating Cycle | 135.87 | 142.91 | 142.07 | 149.93 | 146.91 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.35 | 4.28 | 4.62 | 4.65 | 3.53 |
| Free Cash Flow Per Share | 3.30 | 3.40 | 3.77 | 3.97 | 2.99 |
| Dividend Paid and CapEx Coverage Ratio | 3.64 | 4.28 | 4.91 | 6.82 | 6.48 |
| Capital Expenditure Coverage Ratio | 4.12 | 4.87 | 5.43 | 6.82 | 6.48 |
| Operating Cash Flow Coverage Ratio | 0.20 | 0.21 | 0.21 | 0.24 | 3.68 |
| Operating Cash Flow to Sales Ratio | 0.10 | 0.10 | 0.11 | 0.12 | 0.09 |
| Free Cash Flow Yield | 4.02% | 4.35% | 4.87% | 6.80% | 4.98% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 17.99 | 17.89 | 22.44 | 13.83 | 12.14 |
| Price-to-Sales (P/S) Ratio | 1.82 | 1.81 | 1.80 | 1.44 | 1.55 |
| Price-to-Book (P/B) Ratio | 3.61 | 4.22 | 4.93 | 2.83 | 1.64 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.86 | 23.00 | 20.53 | 14.70 | 20.08 |
| Price-to-Operating Cash Flow Ratio | 18.83 | 18.27 | 16.74 | 12.54 | 16.98 |
| Price-to-Earnings Growth (PEG) Ratio | 4.14 | 0.41 | -0.80 | -1.00 | 1.09 |
| Enterprise Value Multiple | 11.34 | 11.49 | 12.11 | 10.64 | 7.67 |
| Enterprise Value | 42.93B | 42.14B | 42.54B | 33.69B | 27.16B |
| EV to EBITDA | 11.34 | 11.49 | 12.11 | 10.64 | 7.67 |
| EV to Sales | 2.08 | 2.14 | 2.18 | 1.84 | 1.54 |
| EV to Free Cash Flow | 28.51 | 27.18 | 24.82 | 18.69 | 19.99 |
| EV to Operating Cash Flow | 21.60 | 21.60 | 20.25 | 15.94 | 16.90 |
| Tangible Book Value Per Share | -8.81 | -12.20 | -15.12 | -10.44 | 4.74 |
| Shareholders’ Equity Per Share | 22.73 | 18.52 | 15.68 | 20.61 | 36.63 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.21 | 0.31 | 0.22 | 0.21 |
| Revenue Per Share | 45.18 | 43.14 | 42.97 | 40.41 | 38.67 |
| Net Income Per Share | 4.56 | 4.37 | 3.45 | 4.22 | 4.94 |
| Tax Burden | 0.75 | 0.77 | 0.66 | 0.76 | 0.78 |
| Interest Burden | 0.86 | 0.84 | 0.81 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.06 | 0.07 | 0.06 | 0.06 | 0.05 |
| SG&A to Revenue | 0.20 | 0.22 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Income Quality | 0.92 | 0.95 | 1.30 | 1.08 | 0.71 |
Currency in USD
